Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $85.41M.
ENTERPRISE VALUE (EV)
$85.41M
Citius Oncology, Inc.
Market Cap
$85.53M
Enterprise Value (EV)
$85.41M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Citius Oncology, Inc. (CTOR) | $85.53M | $85.41M |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $85.60M | $46.30M |
| Humacyte, Inc. (HUMA)vs › | $84.52M | $70.80M |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.44M | $50.94M |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $83.97M | $90.63M |
| CareCloud, Inc. (CCLD)vs › | $87.11M | $127.73M |
| Cardiff Oncology, Inc. (CRDF)vs › | $88.63M | $79.89M |
| Conexeu Sciences Inc. (CNXU)vs › | $88.84M | N/A |
| ImmuCell Corporation (ICCC)vs › | $89.11M | $92.70M |
| LENSAR Inc (LNSR)vs › | $81.80M | $70.61M |
Market Cap
$85.53M
Total Debt
$3.80M
Cash
$3.92M
Enterprise Value
$85.41M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
